Dashboard
Portfolios
Watchlist
Community
Discover
Screener
Narratives
Your Valuation
🌎 Global
Global
United States
Australia
United Kingdom
Canada
India
China
Argentina
Austria
Bahrain
Bangladesh
Belgium
Bermuda
Botswana
Brazil
Bulgaria
Chile
Colombia
Croatia
Cyprus
Czech Republic
Denmark
Egypt
Estonia
Finland
France
Germany
Ghana
Greece
Hong Kong
Hungary
Iceland
Indonesia
Ireland
Israel
Italy
Ivory Coast
Jamaica
Japan
Jordan
Kenya
Kuwait
Latvia
Lithuania
Luxembourg
Malawi
Malaysia
Malta
Mauritius
Mexico
Morocco
Namibia
Netherlands
New Zealand
Nigeria
Norway
Oman
Pakistan
Palestinian Authority
Peru
Philippines
Poland
Portugal
Qatar
Romania
Russia
Saudi Arabia
Serbia
Singapore
Slovakia
Slovenia
South Africa
South Korea
Spain
Sri Lanka
Sweden
Switzerland
Taiwan
Tanzania
Thailand
Trinidad & Tobago
Tunisia
Turkey
Uganda
Ukraine
United Arab Emirates
Venezuela
Vietnam
Zambia
Zimbabwe
Create a narrative
Global Community
Our community narratives are driven by numbers and valuation.
Create a narrative
Community Investing Ideas
Global Weekly Picks
GXAI
Gaxos.ai
Sponsored
content by Gaxos.ai
JO
Jolt_Communications
Community Contributor
Gaxos.ai: Early-Stage AI Innovator in Gaming & Health
Key Takeaways Dual AI focus – Gaxos.ai builds AI-powered tools for game developers (via Unity integrations) and AI-driven health services under its RNK Health brand. First signs of commercial traction – After years of development, the company reported ~$194k in H1 2025 revenue, mainly from wellness pilot programs.
View narrative
US$2.21
FV
5.9% undervalued
intrinsic discount
119.00%
Revenue growth p.a.
Set Fair Value
1
users have liked this narrative
1
users have commented on this narrative
30
users have followed this narrative
Updated
narrative
Microsoft
PI
PicaCoder
Community Contributor
After the AI Party: A Sobering Look at Microsoft's Future
The world has been captivated by the artificial intelligence boom, and no company has ridden the wave of investor enthusiasm quite like Microsoft. Buoyed by its strategic partnership with OpenAI and the integration of AI across its product ecosystem, the company's valuation has soared to unprecedented heights.
View narrative
US$500.00
FV
1.4% overvalued
intrinsic discount
6.75%
Revenue growth p.a.
Set Fair Value
20
users have liked this narrative
12
users have commented on this narrative
26
users have followed this narrative
12 days ago
author updated this narrative
Amazon.com
ZW
Zwfis
Community Contributor
Amazon's Future Rises as Stock Price Falls: A Long-Term Investment Vision
Amazon is a stock I am very interested in right now especially with the recent price drops that it has been experiencing since its 2Q25 results. A summary of Amazon as stated by Fiscal.ai: "Amazon.com, Inc.
View narrative
US$234.75
FV
2.5% undervalued
intrinsic discount
13.60%
Revenue growth p.a.
Set Fair Value
20
users have liked this narrative
7
users have commented on this narrative
25
users have followed this narrative
New
narrative
Verve Group
TI
TibiT
Community Contributor
Verve Group: A Tale of Three Futures
Verve Group stands at a critical juncture. After a history of explosive growth, the company has been hit by significant operational headwinds, primarily the difficult and costly migration to a unified technology platform and unfavorable currency exchange rates.
View narrative
€4.02
FV
44.5% undervalued
intrinsic discount
8.50%
Revenue growth p.a.
Set Fair Value
3
users have liked this narrative
0
users have commented on this narrative
15
users have followed this narrative
New
narrative
All companies
Popular
Undervalued
Overvalued
Load previous narratives
Capita
AN
AnalystLowTarget
Consensus Narrative from 4 Analysts
Outsourcing Decline Will Pressure Margins Though Digital Efforts Boost Outlook
Key Takeaways Accelerating digital transformation and AI adoption generate strong growth opportunities, but automation threatens traditional outsourcing revenue and margins. Heavy investment in technology and restructuring provides efficiency gains, yet operational complexity, public sector reliance, and talent constraints limit scalability and margin expansion.
View narrative
UK£3.21
FV
26.3% undervalued
intrinsic discount
0.80%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
New
narrative
Natera
AN
AnalystLowTarget
Consensus Narrative from 20 Analysts
Tightening US And European Regulations Will Stunt Diagnostic Developments
Key Takeaways Regulatory challenges and tighter healthcare budgets threaten revenue growth, pricing power, and escalate compliance and operational costs. Intensifying competition and high fixed expenses may prevent Natera from achieving scale, compressing margins and limiting profitability.
View narrative
US$116.83
FV
41.7% overvalued
intrinsic discount
14.05%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
New
narrative
Allied Gold
AN
AnalystLowTarget
Consensus Narrative from 6 Analysts
Political Risks Will Shadow Operations Yet Exploration Offers Hope
Key Takeaways Geographic and operational risks, plus exposure to resource nationalism, threaten revenue stability despite ongoing production growth efforts. Structural cost pressures from inflation, ore grade declines, and ESG compliance may limit margin expansion and undermine long-term earnings resilience.
View narrative
CA$25.22
FV
25.9% undervalued
intrinsic discount
19.89%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
New
narrative
AVITA Medical
AN
AnalystLowTarget
Consensus Narrative from 5 Analysts
High Valuation Will Constrain Recovery Amid Regulatory And Cost Pressures
Key Takeaways Growing reimbursement challenges and payer pressure threaten revenue growth as sustaining premium pricing becomes increasingly difficult. Heavy reliance on RECELL and regulatory setbacks increase risk, while profitability and successful geographic expansion remain uncertain.
View narrative
US$3.00
FV
62.6% overvalued
intrinsic discount
20.92%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
New
narrative
Fenix Resources
AN
AnalystLowTarget
Consensus Narrative from 2 Analysts
Decarbonization Will Cut Iron Ore Demand But Boost Efficiency
Key Takeaways Heavy reliance on a limited mine portfolio and ore grade risks could cap future margins and growth without securing new long-life assets. Rising environmental regulations and changing global steel demand introduce long-term uncertainty and potential volatility in earnings and cash flow.
View narrative
AU$0.40
FV
23.8% undervalued
intrinsic discount
46.65%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
New
narrative
Vanda Pharmaceuticals
AN
AnalystLowTarget
Consensus Narrative from 3 Analysts
Rising Costs And Concentration Will Thwart Stability Yet Spark Recovery
Key Takeaways Reliance on a narrow commercial base and high R&D costs create uncertainty for revenue growth, net margins, and operating leverage amid competitive and regulatory pressures. Expansion efforts and pipeline diversification face challenges from international pricing, reimbursement delays, and market volatility, potentially limiting returns from new launches and partnerships.
View narrative
US$5.00
FV
5.0% undervalued
intrinsic discount
27.55%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
New
narrative
Applied Optoelectronics
AN
AnalystLowTarget
Consensus Narrative from 6 Analysts
Customer Dependence And Price Pressure Will Curtail Margins
Key Takeaways Revenue and earnings are highly vulnerable due to dependence on a few major customers and ongoing margin pressure from industry commoditization and vertical integration. Rising costs from ESG requirements, capacity expansion, and elevated working capital needs threaten profitability and increase financial risks amid uncertain demand.
View narrative
US$15.00
FV
65.3% overvalued
intrinsic discount
45.22%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
New
narrative
Bloom Energy
AN
AnalystLowTarget
Consensus Narrative from 20 Analysts
Renewables And Battery Storage Will Undercut Fuel Cell Market Viability
Key Takeaways Increased competition from zero-carbon alternatives and regulatory changes threatens Bloom's market share, limiting expansion and shrinking future revenue opportunities. Capital intensity and declining pricing power raise risks of shareholder dilution and persistent margin pressure, hindering long-term earnings growth.
View narrative
US$14.00
FV
246.8% overvalued
intrinsic discount
11.14%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
New
narrative
Hesai Group
AN
AnalystLowTarget
Consensus Narrative from 16 Analysts
Geopolitical And Competitive Pressures Will Hinder Lidar Expansion
Key Takeaways Geopolitical tensions, policy shifts, and rising competition threaten global expansion, revenue growth, and margin stability for Hesai's lidar business. Alternative technologies and falling prices risk shrinking Hesai's addressable market and limiting long-term earnings potential.
View narrative
US$24.03
FV
3.2% undervalued
intrinsic discount
38.21%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
New
narrative
Value any company in seconds
Popular companies